243 related articles for article (PubMed ID: 16701973)
41. Influence of peptide dendrimers and sonophoresis on the transdermal delivery of ketoprofen.
Manikkath J; Hegde AR; Kalthur G; Parekh HS; Mutalik S
Int J Pharm; 2017 Apr; 521(1-2):110-119. PubMed ID: 28163223
[TBL] [Abstract][Full Text] [Related]
42. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug.
Kim BS; Won M; Lee KM; Kim CS
Drug Deliv; 2008 Sep; 15(7):465-9. PubMed ID: 18712624
[TBL] [Abstract][Full Text] [Related]
43. Auxiliary substances and applicative properties of model dental gels with ketoprofen and therapeutic saline.
Kołodziejska J; Zgoda MM
Acta Pol Pharm; 2007; 64(5):453-9. PubMed ID: 18540167
[TBL] [Abstract][Full Text] [Related]
44. In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac.
Bonina FP; Puglia C; Barbuzzi T; de Caprariis P; Palagiano F; Rimoli MG; Saija A
Eur J Pharm Sci; 2001 Sep; 14(2):123-34. PubMed ID: 11500258
[TBL] [Abstract][Full Text] [Related]
45. Characterization of the Percutaneous Absorption of Ketoprofen Using the Franz Skin Finite Dose Model.
Bassani AS; Banov D; Phan H
Postgrad Med; 2016; 128(2):262-7. PubMed ID: 26788899
[TBL] [Abstract][Full Text] [Related]
46. Biodegradable Ingredient-Based Emulgel Loaded with Ketoprofen Nanoparticles.
Gul R; Ahmed N; Ullah N; Khan MI; Elaissari A; Rehman AU
AAPS PharmSciTech; 2018 May; 19(4):1869-1881. PubMed ID: 29651679
[TBL] [Abstract][Full Text] [Related]
47. Controlled transdermal delivery of leuprorelin by pulsed iontophoresis and ion-exchange fiber.
Malinovskaja K; Laaksonen T; Hirvonen J
Eur J Pharm Biopharm; 2014 Nov; 88(3):594-601. PubMed ID: 25173088
[TBL] [Abstract][Full Text] [Related]
48. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration.
Rhee YS; Chang SY; Park CW; Chi SC; Park ES
Int J Pharm; 2008 Nov; 364(1):14-20. PubMed ID: 18755258
[TBL] [Abstract][Full Text] [Related]
49. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.
Vučen SR; Vuleta G; Crean AM; Moore AC; Ignjatović N; Uskoković D
J Pharm Pharmacol; 2013 Oct; 65(10):1451-62. PubMed ID: 24028612
[TBL] [Abstract][Full Text] [Related]
50. [Establishment and application of in situ perfused pig ear model for percutaneous absorption].
Hu JH; Zhu QG; Shen Q
Yao Xue Xue Bao; 2003 Oct; 38(10):783-6. PubMed ID: 14730905
[TBL] [Abstract][Full Text] [Related]
51. Transdermal delivery of ketoprofen: the influence of drug-dioleylphosphatidylcholine interactions.
Garcia MT; da Silva CH; de Oliveira DC; Braga EC; Thomazini JA; Bentley MV
Pharm Res; 2006 Aug; 23(8):1776-85. PubMed ID: 16858649
[TBL] [Abstract][Full Text] [Related]
52. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
[TBL] [Abstract][Full Text] [Related]
53. Iontophoretic transdermal delivery of ketoprofen: effect of iontophoresis on drug transfer from skin to cutaneous blood.
Tashiro Y; Kato Y; Hayakawa E; Ito K
Biol Pharm Bull; 2000 Dec; 23(12):1486-90. PubMed ID: 11145183
[TBL] [Abstract][Full Text] [Related]
54. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
[TBL] [Abstract][Full Text] [Related]
55. Transdermal enhancement strategy of ketoprofen and teriflunomide: The effect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch.
Liu C; Guan Y; Tian Q; Shi X; Fang L
Int J Pharm; 2019 Dec; 572():118800. PubMed ID: 31678378
[TBL] [Abstract][Full Text] [Related]
56. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
57. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels.
Cevc G; Mazgareanu S; Rother M
Int J Pharm; 2008 Aug; 360(1-2):29-39. PubMed ID: 18337027
[TBL] [Abstract][Full Text] [Related]
58. Role of volatile oil pretreatment and skin cholesterol on permeation of ion-paired diclofenac sodium.
Sapra B; Gupta S; Tiwary AK
Indian J Exp Biol; 2000 Sep; 38(9):895-900. PubMed ID: 12561947
[TBL] [Abstract][Full Text] [Related]
59. [Percutaneous penetration of ketoprofen and ketoprofen isopropyl ester through a tissue engineering skin reconstructed with HaCaT cells].
Xu YF; Hu JH; Zhu QG; Xu S; Pan YH
Yao Xue Xue Bao; 2005 Sep; 40(9):782-6. PubMed ID: 16342676
[TBL] [Abstract][Full Text] [Related]
60. Controlled transdermal iontophoresis by ion-exchange fiber.
Jaskari T; Vuorio M; Kontturi K; Urtti A; Manzanares JA; Hirvonen J
J Control Release; 2000 Jul; 67(2-3):179-90. PubMed ID: 10825552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
